Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study

authors

Stamatoullas Aspasia
Rezine Imène
Mareschal Sylvain
Lise Ménard Anne
Lanic Hélène
David Marion
Daliphard Sylvie
Penther Dominique
Lemasle Émilie
Cassuto Ophélie
Lenain Pascal
Contentin Nathalie
Leprêtre Stéphane
Jardin Fabrice
Bastard Christian
Tilly Hervé

more information